Cargando…
Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR
Cancer is one of the leading causes of death worldwide and remains a major public health challenge. The introduction of more sensitive and powerful technologies has permitted the appearance of new tumor-specific molecular aberrations with a significant cancer management improvement. Therefore, molec...
Autores principales: | Palacín-Aliana, Irina, García-Romero, Noemí, Asensi-Puig, Adrià, Carrión-Navarro, Josefa, González-Rumayor, Víctor, Ayuso-Sacido, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389639/ https://www.ncbi.nlm.nih.gov/pubmed/34440110 http://dx.doi.org/10.3390/biomedicines9080906 |
Ejemplares similares
-
BRAF V600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors
por: García-Romero, Noemi, et al.
Publicado: (2019) -
Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
por: Li, Daphne, et al.
Publicado: (2021) -
Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients
por: Zmrzljak, Uršula Prosenc, et al.
Publicado: (2021) -
Suppressor of fused associates with dissemination patterns in patients with glioma
por: Peris-Celda, María, et al.
Publicado: (2022) -
Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge
por: Junca, Audelaure, et al.
Publicado: (2020)